恒瑞医药
(600276)
| 流通市值：2785.53亿 | | | 总市值：2787.62亿 |
| 流通股本：63.74亿 | | | 总股本：63.79亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 21,306,321,231.25 | 20,746,104,943.19 | 17,405,890,660.85 | 16,137,972,301.06 |
| 应收票据及应收账款 | 5,133,070,113.96 | 5,520,325,210.17 | 5,956,583,531.87 | 6,230,077,885.39 |
| 其中：应收票据 | 307,987,410.34 | 325,831,647.59 | 331,433,559.84 | 244,314,501.91 |
| 应收账款 | 4,825,082,703.62 | 5,194,493,562.58 | 5,625,149,972.03 | 5,985,763,383.48 |
| 应收款项融资 | 2,177,880,386.32 | 614,581,544.25 | 2,690,307,679.73 | 1,662,901,762.57 |
| 预付款项 | 1,424,698,761.35 | 1,221,081,000.79 | 903,058,119.91 | 1,233,165,245.69 |
| 其他应收款合计 | 528,545,481.51 | 438,253,339.88 | 717,960,488.52 | 726,255,512.43 |
| 存货 | 2,273,245,503.61 | 2,314,026,002.52 | 2,478,935,887.62 | 2,412,286,208.45 |
| 其他流动资产 | 402,076,947.54 | 334,049,541.52 | 265,839,513.89 | 666,762,156.23 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 33,712,251,970.65 | 31,287,471,171.21 | 30,628,112,709.07 | 29,890,953,637.17 |
| 非流动资产: | | | | |
| 长期股权投资 | 672,308,474.09 | 694,990,655.18 | 720,572,025.23 | 726,056,617.1 |
| 其他非流动金融资产 | 596,778,513.03 | 756,391,279.06 | 753,300,147.73 | 750,977,661.78 |
| 固定资产 | 5,450,816,165.7 | 5,451,452,844.8 | 5,264,847,244.21 | 5,319,732,510.46 |
| 在建工程 | 1,041,705,008.89 | 1,100,994,714.83 | 1,366,782,029.88 | 1,290,132,237.39 |
| 使用权资产 | 81,371,149.17 | 77,019,290.13 | 70,140,121.29 | 78,239,519.5 |
| 无形资产 | 871,856,459.98 | 883,766,937.39 | 776,286,193.55 | 774,282,949.84 |
| 开发支出 | 2,812,221,566.44 | 2,492,549,260.85 | 2,349,313,107.51 | 2,147,253,845.48 |
| 长期待摊费用 | 312,494,463.2 | 336,016,444.61 | 336,600,673.88 | 341,927,833.66 |
| 递延所得税资产 | 365,860,975.7 | 320,556,160.87 | 189,363,693.37 | 218,077,721.42 |
| 其他非流动资产 | 422,336,603.99 | 383,297,876.83 | 416,072,795.77 | 423,698,717.06 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 12,627,749,380.19 | 12,497,035,464.55 | 12,243,278,032.42 | 12,070,379,613.69 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 46,340,001,350.84 | 43,784,506,635.76 | 42,871,390,741.49 | 41,961,333,250.86 |
| 流动负债: | | | | |
| 短期借款 | - | - | 16,100,000 | 10,000,000 |
| 应付票据及应付账款 | 1,458,600,980.73 | 1,510,329,134.07 | 1,664,656,918.33 | 1,455,084,443.82 |
| 其中：应付票据 | 203,748,970.78 | 239,910,471.35 | 227,546,186.65 | 149,073,305.07 |
| 应付账款 | 1,254,852,009.95 | 1,270,418,662.72 | 1,437,110,731.68 | 1,306,011,138.75 |
| 合同负债 | 1,451,487,263.71 | 198,090,503.64 | 184,581,972.88 | 217,295,162.84 |
| 应付职工薪酬 | 658,288.26 | 5,363,888.81 | 620,516.37 | 757,106.19 |
| 应交税费 | 249,300,556.07 | 218,969,327.68 | 223,464,723.22 | 244,458,803.19 |
| 其他应付款合计 | 529,322,348.75 | 608,667,928.16 | 343,157,660.51 | 319,986,969.01 |
| 其他流动负债 | 8,702,218.63 | 12,237,845.7 | 12,568,890.34 | 12,386,543.99 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,698,071,656.15 | 2,553,658,628.06 | 2,445,150,681.65 | 2,259,969,029.04 |
| 非流动负债: | | | | |
| 租赁负债 | 78,398,362.45 | 75,176,390.32 | 73,780,020.29 | 76,876,519.04 |
| 递延收益 | 38,950,000 | 38,950,000 | 68,220,000 | 109,440,000 |
| 递延所得税负债 | 85,226,030.16 | 83,635,176.05 | 77,653,903.27 | 79,182,650.3 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 202,574,392.61 | 197,761,566.37 | 219,653,923.56 | 265,499,169.34 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 3,900,646,048.76 | 2,751,420,194.43 | 2,664,804,605.21 | 2,525,468,198.38 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 6,379,002,274 | 6,379,002,274 | 6,379,002,274 | 6,379,002,274 |
| 资本公积 | 3,112,565,084.81 | 3,057,638,970.07 | 3,171,144,289.41 | 3,120,289,504.38 |
| 减:库存股 | 1,101,854,773.92 | 1,091,850,767.15 | 1,200,664,866.96 | 768,416,019.51 |
| 其他综合收益 | 13,180,620.38 | 19,322,555.32 | 14,145,802.31 | 21,972,499.15 |
| 盈余公积 | 3,298,912,011.55 | 3,298,912,011.55 | 3,298,912,011.55 | 3,298,912,011.55 |
| 未分配利润 | 30,171,699,562.75 | 28,802,770,314.9 | 27,974,361,083.63 | 26,808,846,980.62 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 41,873,504,779.57 | 40,465,795,358.69 | 39,636,900,593.94 | 38,860,607,250.19 |
| 少数股东权益 | 565,850,522.51 | 567,291,082.64 | 569,685,542.34 | 575,257,802.29 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 42,439,355,302.08 | 41,033,086,441.33 | 40,206,586,136.28 | 39,435,865,052.48 |
| 负债和股东权益合计 | 46,340,001,350.84 | 43,784,506,635.76 | 42,871,390,741.49 | 41,961,333,250.86 |
| 公告日期 | 2024-04-18 | 2024-04-18 | 2023-10-26 | 2023-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |